pain conditions
Tens of thousands demand menstrual leave to be written into UK law

More than 65,000 people have signed a petition for menstrual leave to be added to UK employment rights law.
The campaign needs 100,000 signatures for a parliamentary debate.
It was launched by Scots mum Michelle Dewar, who endured chronic pain for nine years before being diagnosed with endometriosis – a condition where tissue similar to the womb lining grows outside the womb.
Dewar wants the UK to follow Portugal, which recently introduced paid leave for people with similar conditions. She says protections must include no loss of pay, benefits or seniority.
Endometriosis UK has welcomed the petition but argues the government should go further and recognise menstrual health conditions such as endometriosis and adenomyosis as chronic diseases that deserve the same workplace support as illnesses such as diabetes or asthma.
Writing in the Scottish Sun, Emma Cox, chief executive of Endometriosis UK, said workplace discrimination remains widespread due to limited understanding.
“The taboo and embarrassment around ‘women’s issues’ makes the topic hard or impossible to discuss with managers,” she said.
Examples include fears about being made to wear light-coloured uniforms during heavy bleeding, fluctuating symptoms that lead to staff being unfairly labelled as “flaky”, and absence management policies that penalise people for their condition.
The charity says absenteeism caused by heavy and painful periods, endometriosis, fibroids and ovarian cysts costs the UK economy nearly £11bn each year.
Endometriosis UK is calling for the Employment Rights Bill to require menstrual health action plans in workplaces, giving staff clear guidance on support.
It also wants the NHS to cut diagnosis times, which average eight years and 10 months for endometriosis, and to extend that target to adenomyosis too, aiming for one year or less by 2030.
Cox warned that the term “menstrual leave” could be misleading.
She said: “We fear the term ‘menstrual leave’ could be misunderstood to imply it is for everyone who has periods and could lead to discrimination, or perpetuate the myth that it is ‘normal’ to have severe symptoms and that those who can’t cope are ‘weak’.”
The charity runs an Endometriosis Friendly Employer Scheme and workplace training to help organisations understand the impact of both endometriosis and adenomyosis.
Diagnosis
Women gaslit over hysteroscopy pain, Mumsnet posts reveal

Women have described being dismissed and left in serious pain during routine hysteroscopy examinations, with many given little or no pain relief.
Users of parenting forum Mumsnet who underwent hysteroscopy procedures also shared concerns about receiving unclear information before treatment and being given little or no pain relief afterwards.
Some women, who described feeling physically and emotionally vulnerable, compared the experience to sexual assault.
Research led by the University of Reading analysed 4,644 posts from Mumsnet users written between 2018 and 2024.
Susanne Cromme, lead author from the University of Reading, said: “Women in their thousands say they are going into hysteroscopy procedures unprepared, left in more pain than they were led to expect, and feeling that their experience is not being taken seriously, our analysis shows.
“This is not simply an online pile-on. The themes we found in our research are consistent with what clinical studies already tell us about hysteroscopy.
“But by listening to women talk to each other openly, without a researcher in the room, we get a much richer picture of the issues facing patients.”
The study was published following the launch of the Mumsnet campaign to End Medical Misogyny, which is fighting to end the “systemic dismissal, disbelief or de-prioritisation of women’s symptoms in healthcare”, and comes after health secretary Wes Streeting said the health system “too often gaslights women, treating their pain as an inconvenience.”
Justine Roberts, founder of Mumsnet and Gransnet, said: “This research makes clear that too many women are still experiencing severe pain during hysteroscopy, and that problem is compounded by unclear information, inconsistent pain relief and a lack of proper consent.
“These are not one-off failures, they form a repeated pattern and that’s exactly what Mumsnet’s medical misogyny campaign is highlighting: systemic failings in women’s healthcare.
“Nothing encapsulates that more clearly than the expectation that women should endure avoidable pain during gynaecological procedures. If the NHS is serious about tackling medical misogyny, this has to change.”
Around 71,000 hysteroscopy procedures take place every year in England.
According to the analysed Mumsnet posts, women were told procedures would be no worse than a smear test, felt unable to stop once they had started and found that the pain relief available depended entirely on which NHS trust they attended.
The analysis identified five recurring problems among hysteroscopy patients: not enough information before the procedure; women feeling exposed and unprotected; a “postcode lottery” for pain relief, with wide variation between trusts; pain being played down by staff; and an unequal standard of care.
Women also questioned why sedation routinely offered for procedures such as colonoscopies and endoscopies, which examine the bowel and digestive tract, was not available for gynaecological procedures.
The researchers said the findings suggest the problems go beyond individual clinicians, as the posts reflect wider structural issues in women’s healthcare, including potentially underfunded services and unequal standards of care.
The study calls for NHS trusts to introduce standardised consent processes that give women clear information about pain, alternatives and what to expect.
It also recommends consistent pain management protocols across all hospitals, and training for clinicians in trauma-informed care.
Diagnosis
New NHS pathways aims to speed up endometriosis diagnosis and treatment

A new NHS North West pathway aims to improve treatment and cut waits for people with endometriosis.
The pathway, launched in Cheshire and Merseyside, brings together primary care, secondary care and public health to reduce waiting times and recognise the condition earlier.
Endometriosis affects one in 10 women aged 15 to 45 and currently takes an average of eight years to diagnose.
The programme includes new learning resources for healthcare professionals and a renewed focus on raising public awareness of the condition.
Charlotte Martindale, 30, has had debilitating pain, heavy bleeding, nausea, bowel issues and fatigue for years, but her symptoms were attributed to anxiety and depression.
She said: “When I got to university the pain became unmanageable. I really felt as if I wasn’t being listened to and was made to feel like it was all in my head.”
Charlotte was incorrectly diagnosed with polycystic ovary syndrome (PCOS) before eventually being referred to gynaecology.
She says she was told a laparoscopy, the only definitive diagnostic procedure, would not be offered because she was not trying to conceive.
After 14 years of symptoms, an internal ultrasound finally revealed multiple endometriomas.
She was referred to the endometriosis centre in Preston and underwent surgery in 2025, where deep infiltrating endometriosis was found on her bladder, bowel and appendix, and had stuck her ovaries to her pelvic wall.
Although the surgery was successful, Charlotte has been told it is likely further surgery will be needed as the endometriosis regrows.
Data from the NHS Confederation showed that 84 per cent of women reported being dismissed by medical professionals.
Millie Campbell, 20, is still waiting for a formal diagnosis.
She has had heavy, erratic bleeding, pain and severe bloating since she was 12, but she was told she was “too young” to have endometriosis.
“I’ve been on several different contraceptive pills, but none of them have worked,” she said.
“The pain feels like a ball of barbed wire, and regular pain relief just doesn’t touch it.”
After an MRI last year, she is still waiting to find out whether she will be offered a laparoscopy.
Dr Paula Cowan, NHS England North West’s medical director for primary care and national specialty adviser with the women’s team, says the new approach marks an important step forward, but warns that significant challenges remain.
She said: “Early consideration and recognition of endometriosis is key, both in general practice and in the community. The earlier endometriosis is recognised and diagnosed, the better the care the NHS can give.”
“In this new pathway, we’ve looked closely at how engaging with patients and GPs, workforce planning and better use of data can help reduce waiting lists and ensure people get the help they need.”
“Too many women feel that they have not been listened to regarding their heavy, painful periods are normal.”
“From the very first contact with a patient presenting with heavy painful periods, we need to be thinking could this be endometriosis.”
Dr Cowan says the new pathway is part of a wider commitment to improving women’s health across the region.
Fertility
NICE issues fertility guidance for people with endometriosis

NICE has updated fertility guidance with a new endometriosis section for people struggling to conceive.
This follows feedback received during public consultation, recognising for the first time that the condition requires its own tailored approach to fertility care, separate from other causes of infertility.
Emma Cox, chief executive of Endometriosis UK, said: “This year’s Endometriosis Action Month theme is ‘Endometriosis Doesn’t Wait’ and our new State of Endometriosis Care report shows just how urgently change is needed.
“With average diagnosis times now standing at 9 years and 4 months, and 11 years for those from ethnically diverse communities, many have already waited far too long by the time they reach fertility services.
Today’s guidance marks a step change in the fertility support that anyone with endometriosis should receive.
“For years, those with endometriosis have told us they felt invisible within the fertility system, grouped with unexplained infertility despite having a diagnosed condition.
“We welcome NICE’s decision to listen to patient voices during consultation, to create a dedicated pathway, and to remove misleading labels like ‘mild’ and ‘severe’ endometriosis.”
“Endometriosis doesn’t wait. And now, at last, neither will the guidance.”
Endometriosis UK and others told NICE during consultation that endometriosis was being grouped with unexplained infertility, despite it being a diagnosed condition.
The committee agreed this was inappropriate and that endometriosis requires a distinct fertility pathway.
Respondents also told NICE that terms such as “mild” and “severe” endometriosis were clinically ambiguous and did not reflect the complexity of the condition or its impact on fertility.
The committee agreed and those terms have been removed from the final guideline.
Under the new recommendations, clinicians will discuss a range of options with patients with endometriosis who are trying to conceive, taking into account individual factors including how long they have been trying to conceive, the severity of their symptoms, their age, their ovarian reserve, which is a measure of remaining egg supply, and any male fertility factors.
The guideline sets out a treatment pathway. Where appropriate, expectant management, meaning time to try to conceive naturally, may be offered, or surgical treatment to address endometriosis, in line with NICE’s existing endometriosis guideline (NG73).
If neither approach is suitable or successful after 2 years, fertility treatment options including intrauterine insemination (IUI), where sperm is placed directly into the womb, or IVF will be discussed.
The new guidance supports the ambitions set out in the NHS 10 Year Health Plan, which commits to shifting care closer to home and empowering patients and professionals to make the best choices about treatment.
Setting out a clear, personalised pathway in the guideline for endometriosis helps ensure fertility services are better tailored to individual need, reducing variation in care and supporting equitable access across England.
Eric Power, interim director of the Centre for Guidelines at NICE, said: “We listened carefully to what patients, clinicians and patient groups told us during consultation.
“They described how complex endometriosis is, how they felt existing labels were misleading, and that the condition needed its own pathway. The committee agreed and acted on that feedback.”
“By creating a dedicated section for endometriosis, we are giving clinicians a clear, evidence-based framework to have better, more personalised conversations with their patients, ensuring that everyone, regardless of the cause of their fertility problems, has access to the right care at the right time.”
Public health minister Sharon Hodgson said: “Every woman with endometriosis deserves fertility care that recognises the complexity of her condition.
“This landmark guidance will ensure women can access a clear, personalised pathway to fertility care that leads to clearer conversations with clinicians and fewer barriers.
“We’re committed to giving every woman the support she deserves, and today’s guidance is a significant step towards ending the inconsistency that has let down too many, for too long.”
Entrepreneur3 weeks agoThree sessions that show exactly where women’s health is heading in 2026
Pregnancy3 weeks agoHow NIPT has evolved and what AI NIPT means in 2026
Menopause4 weeks agoWatchdog bans five ads for women’s heath claims
Entrepreneur4 weeks agoWHIS USA 2026 announces first ticket release for landmark Women’s Health Innovation Summit
Menopause4 weeks agoMenopause has no lasting impact on cognition, research finds
News3 weeks agoTwo weeks left to make your mark in women’s cardiovascular health
Opinion3 weeks agoQ1 momentum: Female founders are advancing, but the system still hasn’t caught up
News4 weeks agoEndometriosis firm wins NIH prize













